MedCity News

New FDA Nod Brings Bristol Myers Squibb Cancer Drug to a Wider Range of Solid Tumors

Wheel’s New AI Platform Seeks to Power the New Era of Virtual Care

This week, Wheel rolled out a new AI-powered platform designed to provide patients with more holistic and seamless virtual care journeys. The platform, called Horizon, aims to help the startup’s customers rapidly scale virtual care programs to meet growing patient demand.

By Katie Adams

Payers, Health Tech

Better Health Raises $14M To Reach More Patients with Chronic Conditions

Better Health's $14 million in funding included investments from Healthworx, the University of Miami Health System and Mosaic General Partnership.

By Marissa Plescia

MedCity Influencers

Addressing Healthcare Workforce Shortages Beyond Band-Aids

Solving this problem will require a multi-pronged approach that includes recruitment, technology, and help from lawmakers.

By Charlie Lougheed

Latest News

Pharma BioPharma,

GSK’s Quest to Bring Myeloma Drug Back to the Market Stops for a Data Drop at ASCO

GSK’s Blenrep has pivotal clinical trial results showing the multiple myeloma therapy reduced the risk of disease progression or death by nearly 50%. The results were presented Sunday during the annual meeting of the America Society of Clinical Oncology.

By Frank Vinluan

Health IT, Hospitals, Health Tech, Providers

Why the Cyberattack on Ascension Scared 5 Hospital Execs & How They’re Responding

As majorly disruptive cyberattacks continue to make headlines in the healthcare world, hospitals are prioritizing cybersecurity more than ever before. This piece explores reactions from five different health system executives about the recent attack on Ascension — as well as what they’re doing to prevent a similar fate at their own organization and how they want things to change going forward.

By Katie Adams

Payers

At ViVE 2024, Panelists Share Prior Authorization Progress and Frustration in Payer Insights Program

At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.

MedCity Influencers

Newborn Screening + Genome Sequencing: The Formula for Faster Rare Disease Diagnosis?

Now is the time for the entire industry to understand what newborn screening and newborn sequencing programs are, how they benefit the rare disease community, and how to maximize their benefits.

By Derek Ansel

Pharma BioPharma,

At ASCO, AstraZeneca Adds Data Supporting Expanded Use of Its Drugs in Lung Cancer

AstraZeneca’s Tagrisso and Imfinzi helped patients live longer in separate pivotal clinical trials evaluating the drugs in two different types of lung cancer. The results will be presented Sunday during the annual meeting of the American Society of Clinical Oncology.

By Frank Vinluan

BioPharma, Health Tech

Gameto Secures $33M To Support Clinical Development of Fertility Treatment

Gameto's $33 million Series B funding round was led by Two Sigma Ventures and RA Capital. The funding will help with the clinical development of its in vitro maturation product called Fertilo.

By Marissa Plescia

eBook

Using Informed Awareness to Transform Care Coordination and Improve the Clinical and Patient Experience

This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.

By Care Logistics

MedCity Influencers

How Testosterone is Revolutionizing Menopause Care

Shedding light on misconceptions about testosterone and women’s health

By Dr. Bruce Dorr

Pharma BioPharma,

FDA Approves Moderna RSV Vaccine, an mRNA Alternative to GSK and Pfizer Products

Moderna’s mResvia is now the third FDA-approved RSV vaccine and the first one based on mRNA technology. It will compete for market share against RSV shots from GSK and Pfizer that won their FDA nods last year.

By Frank Vinluan

Unlocking Transparency in PBM Pricing

The TSX Venture Exchange has a strong history of helping early-stage health and life sciences companies raise patient capital for research and development.

Health Tech

Talkspace, Labcorp’s Ovia Health Launch Digital Women’s Health Coalition

Talkspace and Ovia Health by Labcorp introduced the Women’s Health Coalition for Digital Solutions. Other founding member companies of the coalition include Conceive, Evernow, FitOn, Nurx, Cove and Nutrium.

By Marissa Plescia

Pharma, BioPharma

Gilead Sciences ADC Flunks Its Confirmatory Test in Advanced Bladder Cancer

Gilead Sciences reported Trodelvy’s Phase 3 test in metastatic urothelial cancer fell short of showing a statistically significant benefit on the overall survival main goal. The antibody drug conjugate had received accelerated FDA approval for this type of cancer in 2021.

By Frank Vinluan

MedCity Influencers

Experiencing BCBA Burnout? Why It Happens and Tips to Combat It

What contributes to the stress and what BCBA employers can do to alleviate it

By Sharyn Kerr

MedCity Influencers

Work Friction: The Sleeper Crisis Plaguing Healthcare Contact Centers

How work friction takes shape, how it costs organizations, and how leaders can uncover long-term solutions

By Christophe Martel

Health Tech

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Courtney Fortner, CEO of Navvis

In this month’s episode, Senior Reporter Katie Adams explored some executive moves and layoffs that recently occurred in the healthcare world. She also interviewed Courtney Fortner, who stepped into the CEO role at population health company Navvis this month.

By MedCity News

Startups, Pharma, Health Tech Payers,

Healthcare Moves: A Monthly Summary of Hires and Layoffs

Here is a selection of recent executive hires, promotions, retirements and layoffs occurring across the healthcare industry.

By Katie Adams

Social Determinants

Mental Health Inequities Could Cost $1.3 Trillion in 2040. How Can the Industry Prevent This?

Mental health inequities are costing the U.S. $477.5 billion annually. This could rise to $1.3 trillion in 2040 if left unaddressed.

By Marissa Plescia

Events

Here’s Why VC Judges Chose These 4 Startups as INVEST Pitch Perfect Winners

A group of 24 novel startups were selected to pitch at MedCity News' INVEST conference in Chicago. Here's four that VC judges chose as the winners in their respective tracks.

By MedCity News